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Purpose of the study
In Moscow Regional HIV Living Cohort we have
recently defined the groups with progressive HIV infec-
tion and those with temporary and permanently no pro-
gressive disease. The aim of the study was to find major
features of progressive HIV infection in relation to anti-
retroviral treatment.
Methods
In the study 615 progressors were compared with 1311
and 345 temporary and permanently non progressors.
Additionally 208 late presenters (with CD4 counts less
than 100 cells/mm
3) were compared with the sample
from the whole population of people leaving with HIV
(2271 patient). In blood specimens HIV virus load (PCR
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lation of T-lymphocytes were analyzed (flow cytometer
BD FACSCount, sets ÑD3/CD4/CD8/CD45).
Summary of results
The most distinct feature allocating groups was the
response to the elevation of viral load. In the progressive
group the number of CD8 cells among individuals
decreased with the elevation of viral load. This was due
to the T-cell depression including CD8+, CD4+ and
CD3+CD4-CD8- T-lymphocytes.
Contrary to this no progressive groups demonstrated
elevation of CD8 population with the increase of viral
load. The elevation was more expressed in permanently
no progressive group. This resulted in preservation of
CD4 T-lymphocyte subset and CD3+CD4-CD8- T-lym-
phocytes were significantly elevated. Figure 1.
Demonstrated “pathologic process” and “adaptive
response” allows better understanding of the HAART
efficacy. HAART affects the viral replication thus restor-
ing the proportion between the cytotoxic lymphocytes
and virus infected cells. This causes HIV viral load
reduction. Immune reconstitution appears to be a host
property which depends on the severity of the previous
immune impairment.
Among the studied late presenters two groups were
defined. Table 1
Though both groups had pronounced CD4 loss and
high burden of the viral load, the amount of CD8+ and
CD3+CD4-CD8- depletion was different between the
groups and more profound in the first group compared
with the second. For the first group with severe break-
age of immunity combination regiments of HAART
with boosted protease inhibitors, fusion and/or integra-
tion inhibitors are recommended even in the first line of
therapy to obtain better results.
Conclusions
Depletion of different T-cell branches is the major
pathological process in HIV-infection, diagnosis of the
level of immune impairment is needed to prescribe
appropriate treatment.
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Table 1
CD3+ (cells/
mm
3)
CD4+ (cells/
mm
3)
CD8+ (cells/
mm
3)
Viral Load (HIV) (log10 copies/
ml)
CD3+ CD4-CD8- (cells/
mm
3)
Late Presenters First Group 225 38 289 5,47 19
Late Presenters Second
Group
552 26 380 6,09 179
HIV Living Cohort 2363 589 1195 3,80 394
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